• Home
  • CONNEXT Co., Ltd.

CONNEXT Co., Ltd.

About CONNEXT Co., Ltd.

Connext is a clinical-stage biotech company developing recombinant protein therapeutics, CNT101 (TLR5 agonist) and CNT201 (collagenase), in order to improve the quality of life for patients. In addition, we also produce recombinant collagenase and recombinant thermolysin protease using genetic technology.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2024
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
Primary activities
API Producer
Biopharmaceutical
Contact info
Show contact info Hide contact info

Products from CONNEXT Co., Ltd. (1)

  • TDzyme® C (Recombinant collagenase)

    Product TDzyme® C (Recombinant collagenase)

    Connext provides Collagenase (TDzyme® C) derived from Clostridium histolyticum.TDzyme® C is a chromatographically purified mixture of enzymes used for in vitro tissue dissociation and can be used to dissociate various types of cells. We eliminate the use of animal-derived ingredients to meet low endotoxin ...